CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- 4 Open-market buy Chief Executive Officer bought 6,809 shares at $5.04 ($34,317)
- 4 Open-market buy EVP and Chief Medical Officer bought 1,946 shares at $5.04 ($9,808)
- SCHEDULE 13D Stake Beneficial Ownership Report
- 8-K Event Unregistered share sale · Other events
- 8-K Event Material agreement · Unregistered share sale · Bylaws or fiscal year change
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 424B5 Offering Prospectus
- 4 Derivatives Options or other derivatives
- 8-K Event Unregistered share sale
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Shareholder vote results
Page 4 of 25 · 494 filings